Modulation of hepcidin to treat iron deregulation: potential clinical applications
Open accessThe DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Abstract
The secreted peptide hormone hepcidin regulates systemic and local iron homeostasis through degradation of the iron exporter ferroportin. Dysregulation of hepcidin leads to altered iron homeostasis and development of pathological disorders including hemochromatosis, and iron loading and iron restrictive anemias. Therapeutic modulation of hepcidin is a promising method to ameliorate these conditions. Several approaches have been taken to enhance or reduce the effects of hepcidin in vitro and in vivo. Based on these approaches, hepcidin modulating drugs have been developed and are undergoing clinical evaluation. In this article we review the rationale for development of these drugs, the data concerning their safety and efficacy, their therapeutic uses, and potential future prospects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis
Feder, J. N., Gnirke, A., Thomas, W., Tsuchihashi, Z., Ruddy, D. A., Basava, A., Dormishian, F., Domingo, R., Ellis, M. C., Fullan, A., et al. (1996) · Nature Genetics · doi:10.1038/ng0896-399 · Cited by 3,664 · cited 3×
“Mutations in TFR2 or HFE result in partial hepcidin insufficiency, leading to a less severe form of HH.[49,50] It is thought that increasing concentrations of holo-transferrin results in the transfer of HFE from TFR1 to TFR2, stabilizing TFR2 and subsequently activating the downstream SMAD pathway.”
BackgroundNemeth, E., Rivera, S., Gabayan, V., Keller, C., Taudorf, S., Pedersen, B. K., & Ganz, T. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420945 · Cited by 2,650 · cited 13×
“[28] Mass spectrometry (MS) methods, including time-offlight MS and high performance liquid chromatographytandem MS, have also been used for the detection of”
BackgroundMethodInfluentialHepcidin, a urinary antimicrobial peptide synthesized in the liver
Park, C. H., Valore, E. V., Waring, A. J., & Ganz, T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008922200 · Cited by 2,168 · cited 2×
“bioactive peptide hormone.[6,7,9] Hepcidin regulates body iron by binding to FPN, causing the internalization and subsequent degradation of hepci-”
BackgroundPigeon, C., Ilyin, G., Courselaud, B., Leroyer, P., Turlin, B., Brissot, P., & Loréal, O. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008923200 · Cited by 1,697 · cited 4×
“delivery is feasible to the liver,[144] the primary site of systemic hepcidin production.[7] In a related approach, Alnylam Pharmaceuticals, Inc.”
BackgroundInfluentialPositional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter
Donovan, A., Brownlie, A., Zhou, Y., Shepard, J., Pratt, S. J., Moynihan, J., Paw, B. H., Drejer, A., Barut, B., Zapata, A., et al. (2000) · Nature · doi:10.1038/35001596 · Cited by 1,667
Iron and cancer: more ore to be mined
Torti, S. V., & Torti, F. M. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3495 · Cited by 1,621 · cited 1×
“role of hepcidin in promoting cancer growth is still under study, hepcidin appears to be elevated in a number of cancers.[159] Utilizing hepcidin antagonists”
BackgroundSelf-citationHepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein
Nemeth, E., Valore, E. V., Territo, M., Schiller, G., Lichtenstein, A., & Ganz, T. (2003) · Blood · doi:10.1182/blood-2002-10-3235 · Cited by 1,417 · cited 1×
“inflammatory regulation of hepcidin was specific for type II acute phase cytokines, particularly Interleukin-6 (IL-6), and not type I cytokines.[53] Specifically, IL-6”
BackgroundSclerostin Binds to LRP5/6 and Antagonizes Canonical Wnt Signaling
Li, X., Zhang, Y., Kang, H., Liu, W., Liu, P., Zhang, J., Harris, S. E., & Wu, D. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413274200 · Cited by 1,366 · cited 2×
“[14] SOSTDC1, which antagonizes BMP signaling, can also antagonize Wnt signaling by binding to the Wnt receptor LRP5/6.[77] Treatment”
BackgroundLEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity
Krause, A., Neitz, S., Mägert, H.-J., Schulz, A., Forssmann, W.-G., Schulz-Knappe, P., & Adermann, K. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01920-7 · Cited by 1,324 · cited 1×
“Interestingly, hepcidin was first described as an antimicrobial peptide, and it is thought that regulation of hepcidin by inflammation has evolved as a protective mechanism to reduce iron availability for microbes during host infection.[5,52] It”
BackgroundGanz, T., & Nemeth, E. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2012.01.014 · Cited by 1,282
The iron exporter ferroportin/Slc40a1 is essential for iron homeostasis
Donovan, A., Lima, C. A., Pinkus, J. L., Pinkus, G. S., Zon, L. I., Robine, S., & Andrews, N. C. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.01.003 · Cited by 1,275 · cited 1×
“due to their respective roles in uptake of dietary iron and iron recycling (Figure 1).[12] When systemic iron levels are high, hepcidin is produced and targets FPN for degrada-”
BackgroundNicolas, G., Bennoun, M., Devaux, I., Beaumont, C., Grandchamp, B., Kahn, A., & Vaulont, S. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.151179498 · Cited by 1,233
Nair, J. K., Willoughby, J. L. S., Chan, A., Charisse, K., Alam, M. R., Wang, Q., Hoekstra, M., Kandasamy, P., Kel’in, A. V., Milstein, S., et al. (2014) · Journal of the American Chemical Society · doi:10.1021/ja505986a · Cited by 1,141 · cited 1×
“preclinical [145] and clinical [146] studies.”
Identification of erythroferrone as an erythroid regulator of iron metabolism
Kautz, L., Jung, G., Valore, E. V., Rivella, S., Nemeth, E., & Ganz, T. (2014) · Nature Genetics · doi:10.1038/ng.2996 · Cited by 1,127 · cited 6×
“Implicated disorders Inhibit positive regulators SOSTDC1 BMP pathway Cell culture Preclinical [14] Anemia of chronic disease; iron refractory irondeficient anemia Heparins BMP pathway Cell culture, animal models, patients FDA-approved anticoagulant [59,86–90] sHJV.Fc (FMX-8) BMP pathway Cell culture and animal models…”
BackgroundInfluentialBone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression
Babitt, J. L., Huang, F. W., Wrighting, D. M., Xia, Y., Sidis, Y., Samad, T. A., Campagna, J. A., Chung, R. T., Schneyer, A. L., Woolf, C. J., et al. (2006) · Nature Genetics · doi:10.1038/ng1777 · Cited by 1,026 · cited 1×
“Hemojuvelin (HJV) was found to be a critical BMP co-receptor that precisely controls hepcidin expression.[46] Mutations in HJV were identified in humans”
BackgroundMutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis
Roetto, A., Papanikolaou, G., Politou, M., Alberti, F., Girelli, D., Christakis, J., Loukopoulos, D., & Camaschella, C. (2003) · Nature Genetics · doi:10.1038/ng1053 · Cited by 860 · cited 1×
“that develop juvenile hemochromatosis, one of the most severe forms of iron overload.[47,48] These patients were found to have extremely low levels of”
BackgroundHigh levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin
Tanno, T., Bhanu, N. V., Oneal, P. A., Goh, S.-H., Staker, P., Lee, Y. T., Moroney, J. W., Reed, C. H., Luban, N. L., Wang, R.-H., et al. (2007) · Nature Medicine · doi:10.1038/nm1629 · Cited by 854 · cited 2×
“secreted by erythroid precursors: likely erythreferrone and/ or growth differentiation factor 15 (GDF15).[22,23] Similar to HH, low hepcidin levels in turn result in excessive iron absorption and an iron overload phenotype.”
BackgroundThe gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22
Camaschella, C., Roetto, A., Calì, A., De Gobbi, M., Garozzo, G., Carella, M., Majorano, N., Totaro, A., & Gasparini, P. (2000) · Nature Genetics · doi:10.1038/75534 · Cited by 803
BMP6 is a key endogenous regulator of hepcidin expression and iron metabolism
Andriopoulos Jr, B., Corradini, E., Xia, Y., Faasse, S. A., Chen, S., Grgurevic, L., Knutson, M. D., Pietrangelo, A., Vukicevic, S., Lin, H. Y., et al. (2009) · Nature Genetics · doi:10.1038/ng.335 · Cited by 769 · cited 3×
“tion.[43,56,58] Ferrumax Pharmaceuticals, Inc.”
BackgroundMutations in TMPRSS6 cause iron-refractory iron deficiency anemia (IRIDA)
Finberg, K. E., Heeney, M. M., Campagna, D. R., Aydınok, Y., Pearson, H. A., Hartman, K. R., Mayo, M. M., Samuel, S. M., Strouse, J. J., Markianos, K., et al. (2008) · Nature Genetics · doi:10.1038/ng.130 · Cited by 675
Regulation of iron homeostasis by the hypoxia-inducible transcription factors (HIFs)
Peyssonnaux, C., Zinkernagel, A. S., Schuepbach, R. A., Rankin, E., Vaulont, S., Haase, V. H., Nizet, V., & Johnson, R. S. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31370 · Cited by 639 · cited 1×
“mice with hepatocyte deletion of Hif1α did not show a decrease in hepcidin after exposure to hypoxia or iron deficiency.[64] The same study went on to confirm that”
A role of SMAD4 in iron metabolism through the positive regulation of hepcidin expression
Wang, R.-H., Li, C., Xu, X., Zheng, Y., Xiao, C., Zerfas, P., Cooperman, S., Eckhaus, M., Rouault, T., Mishra, L., et al. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.10.010 · Cited by 614 · cited 1×
“[42] Interestingly, there was a 100-fold reduction in”
BackgroundLack of the bone morphogenetic protein BMP6 induces massive iron overload
Meynard, D., Kautz, L., Darnaud, V., Canonne-Hergaux, F., Coppin, H., & Roth, M.-P. (2009) · Nature Genetics · doi:10.1038/ng.320 · Cited by 587
STAT3 mediates hepatic hepcidin expression and its inflammatory stimulation
Verga Falzacappa, M. V., Vujic Spasic, M., Kessler, R., Stolte, J., Hentze, M. W., & Muckenthaler, M. U. (2007) · Blood · doi:10.1182/blood-2006-07-033969 · Cited by 567 · cited 2×
“[54,55] Therapies targeting IL-6 have shown to be effec-”
BackgroundSilvestri, L., Pagani, A., Nai, A., De Domenico, I., Kaplan, J., & Camaschella, C. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.09.012 · Cited by 555 · cited 1×
“and induction of hepcidin.[68] Thus, matriptase-2 is believed to be a negative regulator of hepcidin (Figure 2).”
BackgroundHIF-2α, but not HIF-1α, promotes iron absorption in mice
Mastrogiannaki, M., Matak, P., Keith, B., Simon, M. C., Vaulont, S., & Peyssonnaux, C. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38499 · Cited by 502 · cited 1×
“However, additional studies have suggested that regulation of hepcidin by hypoxia involves solely Hif2α or that regulation of hepcidin by HIFs is indirect.[65,66] Others believe that hypoxia may increase”
BackgroundIRON ABSORPTION AND LOADING IN β-THALASSÆMIA INTERMEDIA
Pippard, M. J., Warner, G. T., Callender, S. T., & Weatherall, D. J. (1979) · The Lancet · doi:10.1016/s0140-6736(79)92175-5 · Cited by 419
Liver iron concentrations and urinary hepcidin in -thalassemia
Origa, R., Galanello, R., Ganz, T., Giagu, N., Maccioni, L., Faa, G., & Nemeth, E. (2007) · Haematologica · doi:10.3324/haematol.10842 · Cited by 365 · cited 1×
“[22,23] Similar to HH, low hepcidin levels in turn result in excessive iron absorption and an iron overload phenotype.[24]”
BackgroundGoswami, T., & Andrews, N. C. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.c600197200 · Cited by 352 · cited 1×
“to TFR2, stabilizing TFR2 and subsequently activating the downstream SMAD pathway.[51] However, the exact molecular pathways that connect HFE-TFR2 and BMP-”
BackgroundHypoxic regulation of erythropoiesis and iron metabolism
Haase, V. H. (2010) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00174.2010 · Cited by 347 · cited 1×
“production of RBC, which results in increased demand for iron.[63] Hepcidin expression must be repressed to achieve this increase in iron.”
BackgroundFurin-mediated release of soluble hemojuvelin: a new link between hypoxia and iron homeostasis
Silvestri, L., Pagani, A., & Camaschella, C. (2008) · Blood · doi:10.1182/blood-2007-07-100677 · Cited by 311
Jiao, Y., Wilkinson, J., Di, X., Wang, W., Hatcher, H., Kock, N. D., D'Agostino, R., Knovich, M. A., Torti, F. M., & Torti, S. V. (2009) · Blood · doi:10.1182/blood-2008-05-155952 · Cited by 266 · cited 3×
“Treatment with curcumin reduced hepatic hepcidin expression in vivo,[113,114] but conversely induced anemia through direct iron chelation.”
BackgroundSelf-citationSasu, B. J., Cooke, K. S., Arvedson, T. L., Plewa, C., Ellison, A. R., Sheng, J., Winters, A., Juan, T., Li, H., Begley, C. G., et al. (2010) · Blood · doi:10.1182/blood-2009-09-245977 · Cited by 251
Competitive regulation of hepcidin mRNA by soluble and cell-associated hemojuvelin
Lin, L., Goldberg, Y. P., & Ganz, T. (2005) · Blood · doi:10.1182/blood-2005-05-1845 · Cited by 241 · cited 1×
“vage of membrane HJV, and HJV can thus transition from a positive regulator of hepcidin to a negative regulator once cleaved.[69] This represents a sophisticated level of hepcidin regulation by utilization of either membrane or soluble”
BackgroundPreza, G. C., Ruchala, P., Pinon, R., Ramos, E., Qiao, B., Peralta, M. A., Sharma, S., Waring, A., Ganz, T., & Nemeth, E. (2011) · Journal of Clinical Investigation · doi:10.1172/jci57693 · Cited by 234 · cited 2×
“developed.[79] These are small 7–9 amino acid peptides that mimic hepcidin function both in vitro and in vivo and were designed to retain the amino acids that were critical for Fpn binding.”
BackgroundValore, E. V., & Ganz, T. (2008) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2007.07.009 · Cited by 234 · cited 1×
“bioactive peptide hormone.[6,7,9] Hepcidin regulates body iron by binding to FPN, causing the internalization and subsequent degradation of hepci-”
BackgroundSong, S.-N. J., Tomosugi, N., Kawabata, H., Ishikawa, T., Nishikawa, T., & Yoshizaki, K. (2010) · Blood · doi:10.1182/blood-2010-03-271791 · Cited by 228 · cited 3×
“levels.[106] Significant reduction of hepcidin and elevated hgb was also observed in a larger cohort of 46 rheumatoid arthritis patients treated with tocilizumab.”
BackgroundInfluentialMinihepcidins prevent iron overload in a hepcidin-deficient mouse model of severe hemochromatosis
Ramos, E., Ruchala, P., Goodnough, J. B., Kautz, L., Preza, G. C., Nemeth, E., & Ganz, T. (2012) · Blood · doi:10.1182/blood-2012-07-440743 · Cited by 213 · cited 2×
“fully prevented iron overload in mouse models of hemochromatosis and reduced basal iron levels in mice.[80] Currently, minihepcidins M009 and M012 are”
Background17β-Estradiol Inhibits Iron Hormone Hepcidin Through an Estrogen Responsive Element Half-Site
Yang, Q., Jian, J., Katz, S., Abramson, S. B., & Huang, X. (2012) · Endocrinology · doi:10.1210/en.2011-2045 · Cited by 208
Schmidt, P. J., Toudjarska, I., Sendamarai, A. K., Racie, T., Milstein, S., Bettencourt, B. R., Hettinger, J., Bumcrot, D., & Fleming, M. D. (2013) · Blood · doi:10.1182/blood-2012-09-453977 · Cited by 204
Ashby, D. R., Gale, D. P., Busbridge, M., Murphy, K. G., Duncan, N. D., Cairns, T. D., Taube, D. H., Bloom, S. R., Tam, F. W. K., Chapman, R., et al. (2010) · Haematologica · doi:10.3324/haematol.2009.013136 · Cited by 191 · cited 1×
“with EPO resulted in a striking reduction of hepcidin transcription and circulating levels, respectively.[61,62] However, additional studies investigating direct regula-”
BackgroundPharmacologic inhibition of hepcidin expression reverses anemia of chronic inflammation in rats
Theurl, I., Schroll, A., Sonnweber, T., Nairz, M., Theurl, M., Willenbacher, W., Eller, K., Wolf, D., Seifert, M., Sun, C. C., et al. (2011) · Blood · doi:10.1182/blood-2011-03-345066 · Cited by 189
Hepcidin regulation in prostate and its disruption in prostate cancer
Tesfay, L., Clausen, K. A., Kim, J. W., Hegde, P., Wang, X., Miller, L. D., Deng, Z., Blanchette, N., Arvedson, T., Miranti, C. K., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-2465 · Cited by 186
Self-citationInhibition of bone morphogenetic protein signaling attenuates anemia associated with inflammation
Steinbicker, A. U., Sachidanandan, C., Vonner, A. J., Yusuf, R. Z., Deng, D. Y., Lai, C. S., Rauwerdink, K. M., Winn, J. C., Saez, B., Cook, C. M., et al. (2011) · Blood · doi:10.1182/blood-2010-10-313064 · Cited by 173
Deletion of TMPRSS6 attenuates the phenotype in a mouse model of β-thalassemia
Nai, A., Pagani, A., Mandelli, G., Lidonnici, M. R., Silvestri, L., Ferrari, G., & Camaschella, C. (2012) · Blood · doi:10.1182/blood-2012-01-401885 · Cited by 161
Schwoebel, F., van Eijk, L. T., Zboralski, D., Sell, S., Buchner, K., Maasch, C., Purschke, W. G., Humphrey, M., Zöllner, S., Eulberg, D., et al. (2013) · Blood · doi:10.1182/blood-2012-09-456756 · Cited by 158
Erythroferrone contributes to recovery from anemia of inflammation
Kautz, L., Jung, G., Nemeth, E., & Ganz, T. (2014) · Blood · doi:10.1182/blood-2014-06-584607 · Cited by 152 · cited 4×
“[132] Preclinical data in nonhuman primates showed that LY2928057 increased serum iron in a dosedependent manner.”
BackgroundInfluentialHeparin: a potent inhibitor of hepcidin expression in vitro and in vivo
Poli, M., Girelli, D., Campostrini, N., Maccarinelli, F., Finazzi, D., Luscieti, S., Nai, A., & Arosio, P. (2011) · Blood · doi:10.1182/blood-2010-06-289082 · Cited by 148
Sham, R. L., Phatak, P. D., West, C., Lee, P., Andrews, C., & Beutler, E. (2005) · Blood Cells, Molecules, and Diseases · doi:10.1016/j.bcmd.2004.12.002 · Cited by 146
Estrogen Regulates Hepcidin Expression via GPR30-BMP6-Dependent Signaling in Hepatocytes
Ikeda, Y., Tajima, S., Izawa-Ishizawa, Y., Kihira, Y., Ishizawa, K., Tomita, S., Tsuchiya, K., & Tamaki, T. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040465 · Cited by 140 · cited 1×
“hepcidin, via GPR30-BMP6-dependent mechanism.[72] Testosterone has also been shown to inhibit hepcidin transcription in mice.”
BackgroundCorradini, E., Schmidt, P. J., Meynard, D., Garuti, C., Montosi, G., Chen, S., Vukicevic, S., Pietrangelo, A., Lin, H. Y., & Babitt, J. L. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.07.044 · Cited by 109 · cited 4×
“[132] Preclinical data in nonhuman primates showed that LY2928057 increased serum iron in a dosedependent manner.”
BackgroundInfluentialIsaacs, J. D., Harari, O., Kobold, U., Lee, J. S., & Bernasconi, C. (2013) · Arthritis Research & Therapy · doi:10.1186/ar4397 · Cited by 105 · cited 1×
“clinical trial for tocilizumab in rheumatoid arthritis patients (n = 70) further confirmed a reduction in hepcidin and increase in hgb.[108] Consistent in each of these studies was a rapid reduction in hepcidin fol-”
ResultCasper, C., Chaturvedi, S., Munshi, N., Wong, R., Qi, M., Schaffer, M., Bandekar, R., Hall, B., van de Velde, H., Vermeulen, J., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-0134 · Cited by 97 · cited 3×
“patients with MCD, siltuximab reduced median hepcidin levels 47% from baseline.[103] The placebo group showed an 11% increase in hepcidin from baseline at”
BackgroundInfluentialVolke, M., Gale, D. P., Maegdefrau, U., Schley, G., Klanke, B., Bosserhoff, A.-K., Maxwell, P. H., Eckardt, K.-U., & Warnecke, C. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007875 · Cited by 93 · cited 1×
“However, additional studies have suggested that regulation of hepcidin by hypoxia involves solely Hif2α or that regulation of hepcidin by HIFs is indirect.[65,66] Others believe that hypoxia may increase”
BackgroundHigh-throughput screening of small molecules identifies hepcidin antagonists
Fung, E., Sugianto, P., Hsu, J., Damoiseaux, R., Ganz, T., & Nemeth, E. (2013) · Molecular Pharmacology · doi:10.1124/mol.112.083428 · Cited by 78
Schmidt, P. J., Racie, T., Westerman, M., Fitzgerald, K., Butler, J. S., & Fleming, M. D. (2015) · American Journal of Hematology · doi:10.1002/ajh.23934 · Cited by 77
Mleczko-Sanecka, K., Roche, F., Rita da Silva, A., Call, D., D’Alessio, F., Ragab, A., Lapinski, P. E., Ummanni, R., Korf, U., Oakes, C., et al. (2014) · Blood · doi:10.1182/blood-2013-07-515957 · Cited by 74 · cited 2×
“and primary murine hepcatocytes, likely through Raf inhibition.[78] Furthermore, paclitaxel and vinorelbine are well described JAK-STAT inhibitors but induce anemia in some patients.”
BackgroundFatih, N., Camberlein, E., Island, M. L., Corlu, A., Abgueguen, E., Détivaud, L., Leroyer, P., Brissot, P., & Loréal, O. (2010) · Journal of Molecular Medicine · doi:10.1007/s00109-009-0588-3 · Cited by 59
Cellular Catabolism of the Iron-Regulatory Peptide Hormone Hepcidin
Preza, G. C., Pinon, R., Ganz, T., & Nemeth, E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058934 · Cited by 56 · cited 1×
“din and FPN in the lysosome.[10,11] FPN expression is most prominent on the surface of enterocytes andmacrophages”
BackgroundAG490: An inhibitor of hepcidin expression in vivo
Zhang, S.-P. (2011) · World Journal of Gastroenterology · doi:10.3748/wjg.v17.i45.5032 · Cited by 35
Böser, P., Seemann, D., Liguori, M. J., Fan, L., Huang, L., Hafner, M., Popp, A., & Mueller, B. K. (2015) · The AAPS Journal · doi:10.1208/s12248-015-9770-4 · Cited by 35 · cited 11×
“[99] In this study, single dose treatment with ABT-207 (200 mg/kg) and h5F9-AM8 (20 mg/kg) increased serum iron and reduced unsaturated iron binding capacity”
BackgroundInfluentialWitcher, D. R., Leung, D., Hill, K. A., De Rosa, D. C., Xu, J., Manetta, J., Wroblewski, V. J., & Benschop, R. J. (2013) · Blood · doi:10.1182/blood.v122.21.3433.3433 · Cited by 29
Hohlbaum, A. M., Trentman, S., Gille, H., Allersdorfer, A., Belaiba, R. S., Huelsmeyer, M., Christian, J., Sandal, T., Matschiner, G., Jensen, K., et al. (2011) · Blood · doi:10.1182/blood.v118.21.687.687 · Cited by 16
Cited by
Iron and cancer: recent insights
Manz, D. H., Blanchette, N. L., Paul, B. T., Torti, F. M., & Torti, S. V. (2016) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13008 · Cited by 507
Self-citationMitochondria and Iron: current questions
Paul, B. T., Manz, D. H., Torti, F. M., & Torti, S. V. (2017) · Expert Review of Hematology · doi:10.1080/17474086.2016.1268047 · Cited by 423
Self-citationIron as a central player and promising target in cancer progression
Jung, M., Mertens, C., Tomat, E., & Brüne, B. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20020273 · Cited by 268
Pharmacological Targeting of the Hepcidin/Ferroportin Axis
Sebastiani, G., Wilkinson, N., & Pantopoulos, K. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00160 · Cited by 127
Iron Deficiency in Obesity and after Bariatric Surgery
Bjørklund, G., Peana, M., Pivina, L., Dosa, A., Aaseth, J., Semenova, Y., Chirumbolo, S., Medici, S., Dadar, M., & Costea, D.-O. (2021) · Biomolecules · doi:10.3390/biom11050613 · Cited by 99
Metadata
- Authors
- Blanchette, N. L., Manz, D. H., Torti, F. M., & Torti, S. V.
- Venue
- Expert Review of Hematology
- Publisher
- Informa UK Limited
- Published
- 2015-12-15
- Volume
- 9
- Issue
- 2
- Pages
- 169-186
- ISSN
- 1747-4086 (ISSN-L)
- 1747-4094
- OpenAlex
- W2220192676
- Cited by
- 59
- References
- 63
- FWCI
- 4.97
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.